[1]李永斌 关英 周馨 钟志清 杨志祥 姚朱华.心脏恶性肿瘤姑息性治疗的个案汇总分析[J].心血管病学进展,2023,(5):450.[doi:10.16806/j.cnki.issn.1004-3934.2023.05.015]
 LI Yongbin,GUAN Ying,ZHOU Xin,et al.Case Summary and Analysis of Palliative Treatment of Cardiac Tumors[J].Advances in Cardiovascular Diseases,2023,(5):450.[doi:10.16806/j.cnki.issn.1004-3934.2023.05.015]
点击复制

心脏恶性肿瘤姑息性治疗的个案汇总分析()
分享到:

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2023年5期
页码:
450
栏目:
综述
出版日期:
2023-05-25

文章信息/Info

Title:
Case Summary and Analysis of Palliative Treatment of Cardiac Tumors
作者:
李永斌1 关英1 周馨1 钟志清1 杨志祥2 姚朱华1
(1.天津市人民医院心内科,天津 300010;2. 天津市人民医院心外科,天津 300010)
Author(s):
LI Yongbin1GUAN Ying1ZHOU Xin1ZHONG Zhiqing1YANG Zhixiang2YAO Zhuahua1
(1. Department of Cardiology,Tianjin Union Medical Center,Tianjin 300010,China; 2. Department of Cardiac Surgery,Tianjin Union Medical Center,Tianjin 300010,China)
关键词:
心脏肿瘤治疗姑息性
Keywords:
Heart neoplasmsTreatmentPalliative
DOI:
10.16806/j.cnki.issn.1004-3934.2023.05.015
摘要:
心脏恶性肿瘤较为罕见,分原发性和转移性,预后极差。由于肿瘤通常与正常心脏解剖结构分界不清,常无法进行手术根治切除。姑息性治疗包括改良的Fontan手术、经皮支架植入、自适应放射治疗等手段,可缓解肿瘤造成的梗阻症状,减轻患者痛苦。现对此方面的个案报道进行汇总,希望能为临床提供治疗思路。
Abstract:
Cardiac malignant tumors are rare,which can be divided into primary and metastatic,and the prognosis is very poor. Due to the unclear boundary between tumors and normal heart anatomical structures,it is often impossible to perform radical surgery. Palliative treatment,including modified Fontan surgery,percutaneous stent implantation,adaptive radiotherapy and other means,can alleviate the obstructive symptoms caused by tumors and alleviate patients pain . We summarize the case reports in this regard,hoping to provide clinical treatment ideas

参考文献/References:




[1] Basso C,Rizzo S,Valente M,et al. Cardiac masses and tumours[J]. Heart,2016,102(15):1230-1245.

[2] 彭建辉,钟铿,韩庆奇,等. 恶性心脏肿瘤外科治疗23例[J]. 中华胸心血管外科杂志,2018,34(11):699-700.

[3] Mo R,Mi L,Zhou Q,et al. Outcomes of surgical treatment in 115 patients with primary cardiac tumours:a 15-year experience at a single institution[J]. J Thorac Dis,2017,9(9):2935-2941.

[4] Hudzik B,Miszalski-Jamka K,Glowacki J,et al. Malignant tumors of the heart[J]. Cancer Epidemiol,2015,39(5):665-672.

[5] Dietl CA. Successful Fontan-type operation for a nonresectable right ventricular tumor[J]. Ann Thorac Surg,1990,50(5):814-816.

[6] Calderón M,Galván J,Negri V,et al. Right ventricular bypass for palliation of cardiac sarcoma[J]. Tex Heart Inst J,1996,23(2):178-179.

[7] Irving JD,Dondelinger RF,Reidy JF,et al. Gianturco self-expanding stents:clinical experience in the vena cava and large veins[J]. Cardiovasc Intervent Radiol,1992,15(5):328-333.

[8] Wallace MJ. Transatrial stent placement for treatment of inferior vena cava obstruction secondary to extension of intracardiac tumor thrombus from hepatocellular carcinoma[J]. J Vasc Interv Radiol,2003,14(10):1339-1343.

[9] Balkin PW,Imoto EM. Treatment of malignant obstruction of the right ventricular outflow tract and pulmonary artery with metallic stents[J]. AJR Am J Roentgenol,1997,169(2):439-440.

[10] Joseph G,Chacko ST,Joseph E,et al. Percutaneous?palliation?of right?ventricular outflow tract obstruction caused by?metastatic malignancy[J]. JACC Cardiovasc Interv,2017,10(8):e79-e80.

[11] Mendiz O,Lev G,Valdivieso L,et al. Lifesaving kissing stent for pulmonary trunk stenosis due to primary angiosarcoma[J]. Ann Vasc Surg, 2010,24(8):1135.e9-e12.

[12] Aviel G,Meirovitz A,Planer D,et al. Endovascular brachytherapy for extensive right-heart and pulmonary artery sarcoma—A case report[J]. J Contemp Brachytherapy,2019,11(6):579-583.

[13] Elsayad K,Scobioala S,Kriz J,et al. Advances in image-guided radiation therapy for primary cardiac angiosarcoma:the role of PET-CT and MRI[J]. Oncol Res Treat,2016,39(5):290-294.

[14] Corradini S,von Bestenbostel R,Romano A,et al. MR-guided stereotactic body radiation therapy for primary cardiac sarcomas[J]. Radiat Oncol,2021,16(1):60.

[15] Zhou M,Ta S,Hahn RT,et al. Percutaneous intramyocardial septal radiofrequency ablation in patients with drug-refractory hypertrophic obstructive cardiomyopathy[J]. JAMA Cardiol,2022,7(5):529-538.

[16] Xie X,Zhou Y,Wu B,et al. Percutaneous transmyocardial ablation of a metastatic adrenocortical carcinoma invading the interventricular septum[J]. Eur Heart J,2021,42(20):2023.

[17] Bruckner BA,Rodriguez LE,Bunge R,et al. Large cardiac tumor managed with resection and two ventricular assist devices[J]. Ann Thorac Surg,2014,97(1):321-324.

[18] Kremer J,Farag M,Arif R,et al. Total artificial heart implantation after undifferentiated high-grade sarcoma excision[J]. Med Sci Monit Basic Res,2016,22:128-131.

[19] 尤士杰,杨跃进,张奎俊. 以室性心动过速为首发临床表现的心脏肿瘤五例[J]. 中华心律失常学杂志,2000,4(4):266.

[20] 杨建都,周公哺,刘旭,等. 心脏肿瘤介导的室性心动过速的治疗[J]. 中国循环杂志,2016,31(z1):45-46.

[21] 邸成业,王明明,林文华. 右心耳起搏电极附近微折返房性心动过速一例[J]. 中国心脏起搏与心电生理杂志,2022,36(2):170-172.

[22] Delanian S,Awad S,de Gramont A. New curative approach using embolization followed by moderate-dose radiotherapy after surgical failure for large right heart metastasis[J]. Clin Transl Radiat Oncol,2022,32:1-5.

相似文献/References:

[1]潘甜 马康华.急性心肌梗死经皮冠脉介入术后冠状动脉无复流的预防和治疗进展[J].心血管病学进展,2019,(5):730.[doi:10.16806/j.cnki.issn.1004-3932019.05.017]
 PAN Tian,MA Kanghua.Prevention and Treatment of Coronary Artery No-Reflow after Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(5):730.[doi:10.16806/j.cnki.issn.1004-3932019.05.017]
[2]雷亚莉 熊峰.心室憩室的诊治进展[J].心血管病学进展,2019,(8):1154.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.021]
 LEI Yali,XIONG Feng.Diagnosis and Treatment of Ventricular Diverticulum[J].Advances in Cardiovascular Diseases,2019,(5):1154.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.021]
[3]李波 郭毅 田进文 邓珏琳.高血压合并2型糖尿病的治疗进展[J].心血管病学进展,2019,(9):1196.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.002]
 LI Bo,GUO Yi,TIAN Jinwen,et al.Therapy in Hypertensive Patients with Type 2 Diabetes Mellitus[J].Advances in Cardiovascular Diseases,2019,(5):1196.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.002]
[4]张明 刘德敏 崔炜.肝素诱导的血小板减少症治疗的研究进展[J].心血管病学进展,2019,(9):1219.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.009]
 ZHANG Ming,LIU Demin,CUI Wei.Teparin-induced Thrombocytopenia Treatment[J].Advances in Cardiovascular Diseases,2019,(5):1219.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.009]
[5]朱永翔 李烽 张耀庭 陆丽洁 龙明智.沙库巴曲缬沙坦在射血分数降低性心力衰竭患者治疗中的研究进展[J].心血管病学进展,2019,(9):1249.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.016]
 ZHU Yongxiang,LI Feng,ZHANG Yaoting,et al.Sacubitril-valsartan for Heart Failure with Reduced Ejection Fraction[J].Advances in Cardiovascular Diseases,2019,(5):1249.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.016]
[6]夏熠 刘飞 夏云龙.糖尿病合并心房颤动的相关研究进展[J].心血管病学进展,2020,(1):27.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.008]
 XIA YiLIU FeiXIA Yunlong.Research Progress in Diabetes Mellitus Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2020,(5):27.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.008]
[7]刘磊 杨震.心肌梗死后左心室壁瘤相关室性心律失常的形成机制与治疗进展[J].心血管病学进展,2020,(1):46.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.013]
 LIU Lei,YANG Zhen.Mechanism and Progress in Treatment of Post-infarction Left Ventricular Aneurysm with Ventricular Arrhythmias[J].Advances in Cardiovascular Diseases,2020,(5):46.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.013]
[8]黄巧娟 周晓莉.冠状动脉慢血流现象的研究进展[J].心血管病学进展,2020,(2):163.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.016]
 HUANG QiaojuanZHOU Xiaoli.Coronary Slow Flow Phenomenon[J].Advances in Cardiovascular Diseases,2020,(5):163.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.016]
[9]毛玉琳 何胜虎.2型糖尿病和慢性心力衰竭[J].心血管病学进展,2020,(5):491.[doi:10.16806/j.cnki.issn.1004-3934.2020.05.012]
 MAO Yulin,HE Shenghu.Type 2 Diabetes Mellitus and Chronic Heart Failure[J].Advances in Cardiovascular Diseases,2020,(5):491.[doi:10.16806/j.cnki.issn.1004-3934.2020.05.012]
[10]张艺文 汪汉 秦莉 杨晓倩 童兰 蔡琳.狼疮患者冠心病的诊断、风险评估和治疗[J].心血管病学进展,2020,(5):513.[doi:10.16806/j.cnki.issn.1004-3934.2020.05.017]
 ZHANG Yiwen,WANG Han,QIN Li,et al.Diagnosis, Risk Evaluation and Therapy of Coronary Heart Disease in Lupus Patients[J].Advances in Cardiovascular Diseases,2020,(5):513.[doi:10.16806/j.cnki.issn.1004-3934.2020.05.017]

更新日期/Last Update: 2023-06-29